The FDA said it plans to unveil new guidelines on the premarket approval of pacemaker and implantable defibrillator leads in 2008 in response to safety concerns over several products. The new guidelines will recommend that device makers conduct further mechanical and electrical bench testing, and postmarket surveillance requirements also may be addressed.

Related Summaries